Compare PFS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PFS | HTFL |
|---|---|---|
| Founded | 1839 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Savings Institutions | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2002 | N/A |
| Metric | PFS | HTFL |
|---|---|---|
| Price | $24.21 | $25.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $23.75 | ★ $38.20 |
| AVG Volume (30 Days) | 946.6K | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.28% | N/A |
| EPS Growth | ★ 112.38 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $73,109,000.00 | N/A |
| Revenue This Year | $0.68 | $27.66 |
| Revenue Next Year | $5.97 | $23.55 |
| P/E Ratio | $39.11 | ★ N/A |
| Revenue Growth | ★ 7.06 | N/A |
| 52 Week Low | $17.61 | $20.13 |
| 52 Week High | $24.56 | $41.22 |
| Indicator | PFS | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.38 | 44.39 |
| Support Level | $21.52 | $24.77 |
| Resistance Level | $24.56 | $32.69 |
| Average True Range (ATR) | 0.41 | 1.60 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 79.30 | 42.41 |
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.